Home
Conditions
Genital Neoplasms, Female

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,595 public trials 1,040 recruiting studies

Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Not Yet Recruiting

A Clinical Study on Alleviating Hemorrhoids-related Symptoms of Pelvic Radiation Therapy

NCT07175584

Conditions: Cervical Cancer Radiation Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

NCT07088731

Conditions: Cervical Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Department of Gynecological Oncology Beijing, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

NCT07177716

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Not Yet Recruiting

The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

NCT07172217

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
Locations: Qilu Hospital of Shandong University Ji'an, Shandong, China

View Trial Details

Not Yet Recruiting

Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer

NCT07170982

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression

NCT07168083

Conditions: Adnexal Diseases, Antibody-drug Conjugates, Clear Cell Adenocarcinoma of Ovary, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Validation of Sophia Genetics Assay

NCT07160010

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +35 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

NCT07153705

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer

NCT07117877

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

NCT07141186

Conditions: Cervical Adenocarcinoma, Cervical Cancer, Cervical Cancer Metastatic, +15 more
Locations: Not specified

View Trial Details

Genital Neoplasms, Female

Genital Neoplasms, Female trial results

Related conditions